About the company

Pharma Assets

The profitability of investments in the pharmaceutical sector far exceeds that of other common investments, such as private or public debt, mortgages, hotels, or solar power plants. This allows Pharma Assets to pay our investors returns that are higher than market averages.

With centers in New York and Panama, our clients invest in high-demand, regulated healthcare sectors that generate monthly payments starting from the very first month of the investment, with capital recovery in 1, 3, or 5 years, depending on the option chosen by the client.

The first public production license was obtained in 2015. We currently hold multiple licenses across different countries. We combine the security of local operations with international distribution capabilities to offer a stable and transparent investment framework.

Pharma Assets manages pharmaceutical investments focused on:

Blood Plasma

According to data obtained via artificial intelligence—which can be viewed on our website:

1. Global revenue in 2025 reached $500 billion USD.
2. The USA is the world's leading producer.
3. USA Exports: It ranks as the country's ninth-largest export product, ahead of gold and coal.
4. The market has seen 8% year-over-year growth over the last 5 years.
5. The market is projected to grow by 20% year-over-year over the next 5 years.
6. Medications produced using blood plasma are used for, among other things:
   • treating burns
   • producing ampicillins to treat infections

Medicinal Cannabis

1. Global revenue in 2025 reached $250 billion USD.
2. The United Kingdom is the world's leading producer of medications made from this botanical product.
3. These medications are used to:
   • treat pain associated with various conditions such as cancer, osteoarthritis, arthritis, etc.
   • eliminate vomiting caused by chemotherapy treatments
   • treat childhood epilepsy